Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Leonabio Inc (LONA)

Leonabio Inc (LONA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Leonabio Inc 18706 North Creek Parkway Suite 104 Bothell WA 98011 USA

www.athira.com Employees: 26 P: 425-620-8501

Sector:

Medical

Description:

LeonaBio Inc. is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for diseases with high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis. Its lead drug candidates include lasofoxifene and ATH-1105. LeonaBio Inc., formerly known as Athira Pharma Inc., is headquartered in the Seattle, Washington.

Key Statistics

Overview:

Market Capitalization, $K 21,810
Enterprise Value, $K -26,630
Shares Outstanding, K 3,944
Float, K 3,163
% Float 80.20%
Short Interest, K 34
Short Float 0.87%
Days to Cover 1.00
Short Volume Ratio 0.56
% of Insider Shareholders 19.80%
% of Institutional Shareholders 57.12%

Financials:

Annual Sales, $ 0 K
Annual Net Income, $ -96,940 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,610 K
EBIT, $ -39,270 K
EBITDA, $ -38,810 K

Growth:

1-Year Return 26.87%
3-Year Return -82.22%
5-Year Return -97.49%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -1.68 on 11/06/25
Next Earnings Date 02/26/26 [--]
Earnings Per Share ttm -9.68
EPS Growth vs. Prev Qtr 6.67%
EPS Growth vs. Prev Year 77.60%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 09/18/25

LONA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -107.06%
Return-on-Assets % -89.89%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 0.70
Book Value/Share 6.80
Interest Coverage -2.21
60-Month Beta 2.72
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar